An alternative synthesis of Azilsartan: an angiotensin II receptor blocker

Journal Title: Current Issues in Pharmacy and Medical Sciences - Year 2015, Vol 28, Issue 2

Abstract

This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and characterization of the novel intermediates (6, 7 & 10) of Azilsartan, with their spectral data.

Authors and Affiliations

Keywords

Related Articles

A comparison of the antioxidant properties of selected edible sprouts of the Legumes family

Germinating seeds of the Legumes family are a natural source of valuable nutrients. The aim of the study was to compare the antioxidant properties of selected edible sprouts from the Legumes family. Lentil and mung bean...

Physical properties and caffeine release from creams prepared with different oils

Caffeine is a methylxanthine typically found in the Coffee Arabica L plant. Generally, caffeine is well-known as a orally administered mild stimulant of the central nervous system. However, for cosmetic purpose, caffeine...

Influence of sterilization on the rheological properties of different types polyacrylic acid gels

The aim of the study was to analyze the influence of sterilization conditions on the rheological properties of gels containing polyacrylic acid derivatives (Carbopols: 974P, Ultrez 10 and Ultrez 20). The gels utilized in...

Characteristics of oral probiotics – a review

Probiotics are a group of microorganisms able to have a positive influence on a host organism when applied in adequate amounts. They are grouped either as: bacteria (mainly Lactobacillus spp and Bifidobacterium) or fungi...

Doxorubicin induces delayed heart and liver mitochondrial depolarisation

The effect of repeated administration of doxorubicin (DOX) on heart and liver morphology, mitochondrial function and redox equilibrium was investigated in rats, contributing in explanation of delayed cardiomyopathy. Male...

Download PDF file
  • EP ID EP148906
  • DOI 10.1515/cipms-2015-0047
  • Views 91
  • Downloads 0

How To Cite

(2015). An alternative synthesis of Azilsartan: an angiotensin II receptor blocker. Current Issues in Pharmacy and Medical Sciences, 28(2), 72-76. https://europub.co.uk/articles/-A-148906